Mirum Pharmaceuticals Q3 EPS $(0.87) Misses $(0.51) Estimate, Sales $185.721M Beat $178.078M Estimate

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.51) by 70.59 percent. This is a 1840 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $185.721 million which beat the analyst consensus estimate of $178.078 million by 4.29 percent. This is a 39.63 percent increase over sales of $133.010 million the same period last year.